Charlie Brindley

Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

Lindsey Cass, Alison D. Murray, Amanda Davis et al. · Pharmacology Research & Perspectives · 2020 · 67 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation

Catherine E. Charron, Paul Russell, Kazuhiro Ito et al. · European Respiratory Journal · 2017 · 48 citations

Life Sciences, Immunology, Pharmacology +17

Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study

John P. DeVincenzo, Lindsey Cass, Alison D. Murray et al. · The Journal of Infectious Diseases · 2020 · 47 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420

Tricia Tan, Benjamin C. T. Field, James Minnion et al. · British Journal of Clinical Pharmacology · 2011 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Safety and efficacy of an extended‐release peptide <scp>YY</scp> analogue for obesity: A randomized, placebo‐controlled, phase <scp>1</scp> trial

Tricia Tan, James Minnion, Bernard Khoo et al. · Diabetes Obesity and Metabolism · 2021 · 29 citations · Full text

Agriculture, Pharmacokinetics, Pharmacology +16